4//SEC Filing
Saltzman Edward C 4
Accession 0001209191-22-049924
CIK 0001549595other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:25 PM ET
Size
5.5 KB
Accession
0001209191-22-049924
Insider Transaction Report
Form 4
Saltzman Edward C
Director
Transactions
- Award
Director Stock Option (right to buy)
2022-09-12+50,000→ 50,000 totalExercise: $16.29Exp: 2032-09-11→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/36 of the total shares monthly beginning October 12, 2022 until the option is fully vested on September 12, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001946233
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:25 PM ET
- Size
- 5.5 KB